B, B., A, G., R, G., D, A., JW, P., AS, N., . . . JM, B. (2013). Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. British journal of cancer, 108(10), 2045. https://doi.org/10.1038/bjc.2013.214
Chicago Style (17th ed.) CitationB, Burford, et al. "Autoantibodies to MUC1 Glycopeptides Cannot Be Used as a Screening Assay for Early Detection of Breast, Ovarian, Lung or Pancreatic Cancer." British Journal of Cancer 108, no. 10 (2013): 2045. https://doi.org/10.1038/bjc.2013.214.
MLA (9th ed.) CitationB, Burford, et al. "Autoantibodies to MUC1 Glycopeptides Cannot Be Used as a Screening Assay for Early Detection of Breast, Ovarian, Lung or Pancreatic Cancer." British Journal of Cancer, vol. 108, no. 10, 2013, p. 2045, https://doi.org/10.1038/bjc.2013.214.